| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT01318278 | Hypotension | Drug: Dopamine|Drug: Arginine Vasopressin | Baylor College of Medicine|Thrasher Research Fund | | 2011-03-01 | 2015-02-24 |
| NCT02053935 | Hyperglycemia|Sepsis | Drug: Dopamine | Albert Einstein College of Medicine, Inc. | Phase 1 | 2013-12-01 | 2016-08-05 |
| NCT01427686 | Arterial Hypotension | Drug: Dobutamine|Drug: Dopamine | University of Ulm | Phase 4 | 2011-06-01 | 2016-04-05 |
| NCT01780467 | Parkinson's Disease | Behavioral: Role of dopamine | University Hospital, Clermont-Ferrand | Phase 4 | 2013-03-01 | 2013-01-29 |
| NCT00604019 | Septic Shock | Drug: Dopamine|Drug: Norepinephrine | Rush University Medical Center | Phase 3 | 2003-03-01 | 2013-02-26 |
| NCT00115115 | Kidney Transplantation|ESRD | Drug: Dopamine infusion to brain dead organ donors | Universittsmedizin Mannheim|Eurotransplant International Foundation, Leiden, The Netherlands|Regional Organ Procurement Organization (DSO), Baden-Wuerttemberg, Germany|Regional Organ Procurement Organization (DSO), Bavaria, Germany|Novartis | Phase 4 | 2004-03-01 | 2009-04-22 |
| NCT00038116 | Parkinson Disease | Procedure: embryonic dopamine cell implant surgery|Procedure: placebo | University of Colorado, Denver | Phase 3 | 1995-05-01 | 2013-02-04 |
| NCT02402101 | Transcranial Direct Current Stimulation|Dopamine | Device: Procedure: active tDCS|Device: Procedure: sham tDCS | Hpital le Vinatier | Phase 3 | 2015-02-01 | 2016-08-22 |
| NCT00937092 | Acute Heart Failure | Drug: Furosemide|Drug: low-dose dopamine + low-dose furosemide | Larissa University Hospital | Phase 4 | 2009-01-01 | 2010-05-25 |
| NCT03059563 | Dopamine D2/3 Receptor Availability|Cognitive Function|Methamphetamine Abuse | Drug: Varenicline|Other: Placebo | University of California, Los Angeles|Tarzana Treatment Center | Phase 1 | 2017-04-01 | 2017-02-16 |
| NCT00396669 | Tobacco Use Disorder | Drug: Bupropion|Drug: Bupropion | Hadassah Medical Organization | | 2007-07-01 | 2012-03-26 |
| NCT01901809 | Heart Failure, Diastolic | Drug: Furosemide|Drug: Dopamine | Johns Hopkins University | Phase 4 | 2013-08-01 | 2017-03-07 |
| NCT02201121 | Circulation|Drug Dose|Calculated SAP | Other: Influences of phenylephrine, dopamine and ephedrine on stroke volume variation and pulse pressure variation | Chinese PLA General Hospital | | 2014-03-01 | 2014-07-24 |
| NCT00942253 | Restless Legs Syndrome|End Stage Renal Disease|Hemodialysis|Muscle Cachexia|Sleep Disorders | Other: Dopamine Agonist and Exercise | University of Thessaly|Center for Research and Technology Thessaly - CERETETH|European Social Fund | Phase 2 | 2006-09-01 | 2010-07-02 |
| NCT01060293 | Acute Decompensated Heart Failure | Drug: High-dose furosemide|Drug: Low-dose furosemide|Drug: Low-dose furosemide combined with low-dose dopamine | Larissa University Hospital | Phase 4 | 2009-07-01 | 2013-09-10 |
| NCT00670293 | Eating Disorders | Radiation: Positron Emission Tomography (PET) using [11C]raclopride|Drug: Methylphenidate|Procedure: Magnetic Resonance Imaging (MRI) scan | New York State Psychiatric Institute|National Institute of Mental Health (NIMH) | | 2008-07-01 | 2016-04-06 |
| NCT01906411 | Adiposity|Weight Loss | Dietary Supplement: Dopamine depletion vs. Balanced aminoacid drink | University Hospital Tuebingen | | | 2015-05-28 |
| NCT02148783 | Traumatic Brain Injury | Drug: methylphenidate|Drug: Placebo | Uniformed Services University of the Health Sciences|National Institutes of Health (NIH) | Phase 2 | 2014-09-01 | 2014-05-27 |
| NCT02347059 | Parkinson's Disease | Drug: L-dopa|Drug: Dopamine Agonists (pramipexole, ropirinole) | University of Toronto|Michael J. Fox Foundation for Parkinson's Research | Phase 2 | 2015-01-01 | 2015-01-26 |
| NCT01365364 | Periodic Limb Movements in Sleep | Behavioral: Aerobic Physical Exercise|Behavioral: Aerobic Physical Exercise | Federal University of So Paulo|Fundao de Amparo Pesquisa do Estado de So Paulo|Associao Fundo de Incentivo Pesquisa | | 2009-03-01 | 2011-06-02 |
| NCT01722630 | Intra Operative Fluid Management | Drug: Dopamine | Catholic University of the Sacred Heart | | 2012-03-01 | 2012-11-05 |
| NCT00314704 | Shock | Drug: dopamine versus norepinephrine | Sepsis Occurrence in Acutely Ill Patients | Phase 3 | 2003-12-01 | 2010-01-29 |
| NCT01264861 | Parkinson Disease | Drug: Safinamide | Newron | Phase 2 | 2010-12-01 | 2013-03-28 |
| NCT00940914 | Parkinson's Disease|Pain | Drug: ioflupane 123I (DATSCAN) | University Hospital, Toulouse | Phase 2 | 2009-03-01 | 2011-03-29 |
| NCT01160263 | Amyotrophic Lateral Sclerosis | Drug: SPECT : 123 I-FP-CIT (DATSCAN) and 123I-ADAM | Assistance Publique - Hpitaux de Paris|Association Franaise contre les Myopathies (AFM), Paris|ARS (Association pour la Recherche sur la Sclrose Latrale Amyotrophique)|Agence Gnrale des Equipements et Produits de Sant | Phase 3 | 2012-10-01 | 2015-05-12 |
